Please be aware of scams that can affect investors.
The Company currently conducts its affairs so that securities issued by Aberdeen New Dawn Investment Trust PLC can be recommended by financial advisers to ordinary retail investors in accordance with the FCA’s rules in relation to non-mainstream pooled investment products (NMPIs) and intends to continue to do so for the foreseeable future.
The Company’s securities are excluded from the FCA’s restrictions which apply to non-mainstream investment products because they are securities in an investment trust.
The Alternative Investment Fund Manager Directive (“AIFMD”) requires Aberdeen Fund Managers Limited, as the alternative investment fund manager of Aberdeen New Dawn Investment Trust PLC, to make available to investors certain information prior to such investors’ investment in the Company.
The AIFMD is intended to offer increased protection to investors in investment products that do not fall under the existing European Union regime for regulation of investment products known as “UCITS”.
The value of investments and the income from them may go down as well as up and investors may get back less than the amount invested. The tax benefits relating to ISA investments may not be maintained. Please refer to the Key Facts documents contained in the ISA/Share Plan Brochure & Application form for general and specific investment risks attaching to the individual trusts.Read the detailed Risk Warning
Past performance is not a guide to future results.
See latest monthly factsheet below for performance history.
At close 30-Sep-2014Ord
|Net Dividend Yield||2.03%|
Source: Morningstar, NAV = Net Asset Value, excluding income.
Bow Bells House,
1 Bread Street,
Registered in England and Wales as an Investment Company Number 2377879
To provide shareholders with a high level of capital growth through equity investment in the Asia Pacific countries excluding Japan. In addition, it is the Investment policy of the Company to invest in no more than 15 per cent of its gross assets in other listed investment companies (including listed investment trusts).
In this webcast James Thom gives an update on a wide range of subjects including performance, a sector breakdown, the twenty largest investments and an outlook for the Trust.Click here to listen to the presentation.
Uneven economic growth and the prospect of higher US interest rates jostled against hopes of additional stimulus in Europe, returning mixed US dollar-based performances across Asian markets in August.
During the month, we pared Ayala Land on price strength. We also sold Keppel REIT, which we had received through the holding in Keppel Corp.
With the proceeds, we introduced CSL, an Australia-listed biopharmaceutical company that is a leading player in the global plasma products market. The company has robust quality control and enjoys superior growth and returns because of its highly-efficient collection and processing system, coupled with its commitment to research and development. It is financially strong and any excess free cashflows have been used for share buybacks, enhancing shareholder value.
In corporate news, OCBC plans to raise S$3.37 billion in a rights issue to fund its acquisition of Hong Kong bank Wing Hang. On the results front, the Singapore lender, along with compatriots DBS and UOB, reported good loan growth and robust capital adequacy. Standard Chartered and QBE Insurance’s lower profits were in line with their earlier guidance. The former remains comfortably capitalised and poised to capture long-term growth in emerging markets, while the latter continues to cut costs and boost its capital position. Meanwhile, HSBC’s earnings fell as good performance in commercial banking was overshadowed by softer revenues in global banking and retail. Positively, asset quality improved. China Mobile posted higher data revenues, but profits fell because of increased expenses and subsidies related to the rollout of 4G handsets and base stations. Nevertheless, the telco made good progress in growing its 4G subscriber base.
Interest rate decisions taken by major central banks will continue to shape the direction of capital flows into Asia. While Europe and Japan are expected to keep rates pinned to the floor, the US recovery has given investors reason to worry about an earlier-than-expected normalisation of Fed policy. This could result in market volatility over the short term as the cost of capital rises and liquidity declines. Uncertainty is also likely to persist should tensions in Ukraine spike amid claims of widespread Russian troop presence and violence in the Middle East escalate. On the other hand, the prospect of continued selective stimulus in China and additional quantitative easing in Europe could help buffer against any market downside, while gradually improving demand from the US should underpin Asian exports. We remain watchful, but take comfort in the strength of our holdings, which we believe will withstand the current headwinds. Their focus on controlling costs and improving margins should reap dividends when the cycle turns.
Source: Monthly Factsheet Aberdeen Asset Managers Limited